MedTrace Logo

CNS Changes Following Upper Limb Loss

NCT06043518 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2025-11-19

No results posted yet for this study

Summary

The objective of this study is to better understand the structural and functional changes that the central nervous system (CNS) undergoes following congenital upper limb loss. The focus is on the brain's sensory processing and how neuronal changes may relate to clinical measures. By doing so, the hope is to gain insight into the contribution of critical periods to the plasticity of the sensorimotor processing stream. Both macroscopic and microscopic changes of the brain will be examined in individuals with upper limb amelia and compared to healthy controls. fMRI will be combined with behavioural testing to understand which clinical and behavioural determinants drive somatosensory representations along the entire somatosensory processing stream. Using advanced imaging techniques, the aim is to investigate the contribution of brainstem reorganisation to plasticity observed at the cortical level and, by doing so, gain a better understanding of the mechanistic underpinnings of functional reorganisation. Overall, the hope is to provide the first mechanistic insight into whether early life experiences are crucial for the development of the relay nuclei in the central nervous system and how these changes relate to clinical measures such as adaptive behaviours or pain.

Conditions

  • Amputation, Congenital
  • Upper Limb; Amelia

Interventions

DIAGNOSTIC_TEST

MRI

Use of functional and structural MRI in both the brain and the spinal cord as well as questionnaires and clinical measures of motor function

DIAGNOSTIC_TEST

MRI

Use of functional and structural MRI in both the brain and the spinal cord and questionnaires.

Sponsors & Collaborators

  • ETH Zurich

    collaborator OTHER

  • University of Zurich

    lead OTHER

Principal Investigators

  • Patrick Freund, Prof. · University of Zurich

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-05
Primary Completion
2027-06-30
Completion
2027-06-30

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06043518 on ClinicalTrials.gov